Search for Clinical Trial Results
Carcinoma, Merkel Cell - 25 Studies Found
Status | Study |
Recruiting |
Study Name: QUILT-3.009: Study of aNK Infusions in Combination With ALT-803 in Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) Condition:
|
Completed |
Study Name: S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer Condition: Neuroendocrine Carcinoma of the Skin Date: 1999-11-01 Interventions:
|
Active, not recruiting |
Study Name: Cabozantinib in Recurrent/Metastatic Merkel Cell Carcinoma Condition:
Date: 2013-12-19 Interventions: Drug: Cabozantinib Cabozantinib 60 mg Oral Daily 28 days (4 weeks) |
Completed |
Study Name: A Phase I, Exploratory, Intra-patient Dose Escalation Study to Investigate the Preliminary Safety, Pharmacokinetics, and Anti-tumor Activity of Pasireotide (SOM230) s.c.Followed by Pasireotide LAR in Patients With Metastaticmelanoma or Metastatic Merkel Cell Carcinoma Condition: Metastatic Melanoma and Merkel Cell Carcinoma Date: 2012-07-12 Interventions:
|
Active, not recruiting |
Study Name: Merkel Positron Emission Tomography (PET) Protocol Condition: Merkel Cell Carcinoma Date: 2009-11-12 Interventions:
|
Recruiting |
Study Name: Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma Condition:
Date: 2017-03-01 Interventions:
|
Active, not recruiting |
Study Name: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer Condition:
|
Recruiting |
Study Name: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma Condition:
|
Completed |
Study Name: S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Condition:
|
Recruiting |
Study Name: A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors Condition:
|